A functional linkage between SPIB expression and TLR/MYD88 pathway activation has been identified by Yang et al. in which SPIB represses autocrine IFN secretion allowing ABC-DLBCL survival in the context of MYD88 mutation (16). Here, SPIB is linked to diffuse large B-cell lymphoma.